EAGER: Engineering Molecular Sensors Of Endoplasmic Reticulum-Associated Degradation (ERAD)

EAGER：内质网相关降解（ERAD）的工程分子传感器

• 批准号: 1112783
• 负责人: Laura Segatori
• 金额: $ 10万
• 依托单位: William Marsh Rice University
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-05-01 至 2013-04-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1112783&HistoricalAwards=false
• 关键词: EAGER; Engineering; Molecular; Sensors; Endoplasmic

This NSF award by the Biotechnology, Biochemical and Biomass Engineering program supports the development of novel tools that will aid researchers in the discovery of enhancers of degradation of misfolded proteins that are processed by cells. The degradation of misfolded proteins is important both in bioprocessing and in medicine, as one of the biggest problems in expression of certain recombinant therapeutic proteins is the intracellular aggregation of these proteins. Proteins which are targeted for secretion that accumulate as aggregated or misfolded proteins inside cells cause cellular stress and eventually cell death via apoptosis, leading to loss of productivity in bioprocessing applications. In diseases such as Alzheimer's or Parkinson's, the presence of an aggregated protein appears to lead to neurodegeneration. In protein misfolding diseases, endoplasmic reticulum or ER stress may play a role in cell death. The enhancement of mechanisms which would lead to degradation of those proteins might slow down the progression of disease. In this project, the investigators propose to develop a novel fluorescence based assay for the detection of the activation of a specific protein degradation pathway (ER-degradation). This assay is the first step in being able to develop high throughput screens for molecules that will enhance intracellular degradation of misfolded proteins. The assay will have applications both in the bioprocessing industry and in biomedicine. The PI will integrate research and education at the graduate and undergraduate levels, and work to increase the diversity of the biotechnology field.

生物技术，生物化学和生物质工程计划的NSF奖项支持开发新工具，帮助研究人员发现细胞处理的错误折叠蛋白质降解的增强剂。 错误折叠蛋白质的降解在生物加工和医学中都很重要，因为某些重组治疗蛋白质表达的最大问题之一是这些蛋白质的细胞内聚集。 靶向分泌的蛋白质作为聚集或错误折叠的蛋白质在细胞内积累，引起细胞应激并最终通过细胞凋亡导致细胞死亡，导致生物加工应用中生产率的损失。在阿尔茨海默氏症或帕金森氏症等疾病中，聚集蛋白的存在似乎会导致神经变性。 在蛋白质错误折叠疾病中，内质网或ER应激可能在细胞死亡中起作用。 增强导致这些蛋白质降解的机制可能会减缓疾病的进展。 在该项目中，研究人员提出开发一种新的基于荧光的检测方法，用于检测特定蛋白质降解途径（ER-降解）的激活。 该测定是能够开发高通量筛选将增强错误折叠蛋白质的细胞内降解的分子的第一步。 该分析将在生物加工工业和生物医学中具有应用。PI将整合研究生和本科生水平的研究和教育，并致力于增加生物技术领域的多样性。